Generic drugmaker Mallinckrodt may file for a second bankruptcy, putting a $1.7 billion opioid settlement in peril.
Here & Now‘s Scott gets the latest from NPR’s Brian Mann.
This article was originally published on WBUR.org.
Copyright 2023 NPR. To see more, visit https://www.npr.org.
